REVEALED: William blair - The Real Truth

Ahead of Chevron Earnings, Here's What Barchart Data Says Comes Next for CVX Stock

Chevron is set to report its fiscal Q3 earnings on Oct. 30. Options data signals potential for a post-earnings rally in CVX shares.

Barchart · 9h ago

Bristol Myers Pulmonary Fibrosis Drug Admilparant Met Main Goal at 60 mg, but Higher Dose Missed

BMS said Admilparant met its phase 3 goal in pulmonary fibrosis at 60 mg, but 120 mg missed. Data are topline. What patients and families should know.

Medical Daily · Oct 15

Argenx Stops Phase 3 Vyvgart Trial in Sjögren's Disease After Monitors Find the Study Cannot Meet Its Goal

Argenx ended its Phase 3 UNITY trial of efgartigimod in Sjögren's disease after a futility review. No new safety signals were found.

Medical Daily · Oct 13

Microsoft’s stock has biggest one-day gain since 2008, adding $480 billion in market value as cloud business booms

Azure crossed $100 billion in revenue for the first time, and a new disclosure about OpenAI offered some respite.

Fortune · Jul 30

If You Lack Conviction in This Market, Here’s 1 Stock William Blair Thinks Deserves Your Attention

William Blair just added ORCL stock to its conviction list, with Oracle expected to be a major AI beneficiary.

Barchart · Jul 3

Black Rock Coffee Bar Targets 1,000 Stores as Loyalty Fuels Growth Plan

Black Rock Coffee Bar (NASDAQ:BRCB) executives outlined the company’s growth strategy, store economics and competitive positioning during a William Blair consumer event, emphasizing plans to sustain rapid unit expansion while leaning on customer loyalty, store-level execution and a differentiated ca

MarketBeat · Jun 6

BlackLine Says AI Agents, Platform Pricing Can Reignite Revenue Growth

BlackLine (NASDAQ:BL) executives said the company is leaning on platform pricing, artificial intelligence and deeper enterprise adoption as it works to reaccelerate revenue growth, according to remarks at a William Blair conference session. Chair and CEO Owen Ryan described BlackLine as a “mission-

MarketBeat · Jun 6

AeroVironment Sees Drone Demand Taking Off as Switchblade, Counter-Drone Capacity Expands

AeroVironment (NASDAQ:AVAV) executives told investors at William Blair’s 46th Annual Growth Stock Conference that the company sees expanding opportunities across drones, loitering munitions and counter-drone systems, while also emphasizing ongoing capacity investments tied to programs such as Switch

MarketBeat · Jun 6

argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference

argenx (NASDAQ:ARGX) Chief Financial Officer Karl Gubitz told investors at the 46th Annual William Blair Growth Stock Conference that the biotechnology company remains focused on revenue growth, profitability and execution as it expands the VYVGART franchise and advances additional pipeline assets.

MarketBeat · Jun 5

Align Technology Pitches AI-Powered Digital Dentistry Platform Beyond Invisalign

Align Technology (NASDAQ:ALGN) executives used a William Blair investor presentation to emphasize the company’s broader digital dentistry platform, positioning Invisalign as part of a workflow that spans consumer engagement, scanning, treatment planning, monitoring and retention. President and CEO

MarketBeat · Jun 3